Get alerted on the PharmaSources E-Newsletter and Pharma Sources Insight E-Compilation!
Note: You can unsubscribe from the alerts at any time.
Advertising

Connect Biopharma Reports Positive Topline Data from Moderate-to-severe Atopic Dermatitis (AD) Phase 1b Study of CBP-201

prnasiaJanuary 09, 2020

Tag: Moderate-to-Severe Atopic Dermatitis , Connect Biopharma , Positive Topline Data

PharmaSources Customer Service